{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:36:43Z","timestamp":1787531803536,"version":"build-2736575974"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000313","name":"BSAC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000313","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Reporting of outpatient parenteral antimicrobial therapy (OPAT) outcomes with national benchmarking is key to informing service development and supporting quality improvement.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To analyse and report on data collected by the BSAC OPAT National Outcomes Registry from 2015 to 2019.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Quarterly data to 2020 was extracted from the BSAC National Outcomes Registry and analysed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>57 organizations submitted data on 27 841 patient episodes and 442 280 OPAT treatment days. A diverse range of infections and antimicrobials were reported with a mean OPAT treatment duration of 16.7\u2005days (adults) and 7.7\u2005days (paediatrics). In adults, the top five conditions treated were skin and soft tissue (27.6%), bronchiectasis (11.4%), urinary tract infections (7.6%), and diabetic foot infections (5.5%). Ceftriaxone followed by teicoplanin, ertapenem and piperacillin\/tazobactam were the most-used antimicrobials. A median of 1.4 vascular-device-related complications were observed per 1000 OPAT treatment days (range 0.11 to 10.4) with device infections in 0.3 per 1000 OPAT days (range 0.1 to 1.7). Other adverse events (rash, blood dyscrasias, antibiotic-associated diarrhoea) were observed in a median of 1.9 per 1000 OPAT days. OPAT infection outcome (cured\/improved) was 92.4% and OPAT outcome (success\/partial success) was 90.7%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This report demonstrates the safety, breadth, and complexity of modern UK OPAT practice. Future analyses of OPAT data should focus on infection- and service-specific quality indicators. OPAT registries remain central to planning and assessing safe, effective, and efficient delivery of patient-centred care and should be an important focus for UK and global OPAT practice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkac047","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T12:08:45Z","timestamp":1644494925000},"page":"1481-1490","source":"Crossref","is-referenced-by-count":49,"title":["Outpatient parenteral antimicrobial therapy (OPAT) in the UK: findings from the BSAC National Outcomes Registry (2015\u201319)"],"prefix":"10.1093","volume":"77","author":[{"given":"Mark","family":"Gilchrist","sequence":"first","affiliation":[{"name":"Imperial College Healthcare NHS Trust, London, UK"},{"name":"National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, UK"},{"name":"Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Campus, Du Cane Road, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2922-9381","authenticated-orcid":false,"given":"David","family":"Barr","sequence":"additional","affiliation":[{"name":"University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity","family":"Drummond","sequence":"additional","affiliation":[{"name":"British Society for Antimicrobial Chemotherapy, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Muir","sequence":"additional","affiliation":[{"name":"Lancashire Teaching Hospitals NHS Foundation Trust, Royal Preston Hospital, Preston, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Williams","sequence":"additional","affiliation":[{"name":"The James Cook University Hospital, Middlesbrough, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Scriven","sequence":"additional","affiliation":[{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Snape","sequence":"additional","affiliation":[{"name":"Nottingham University Hospital NHS Trust, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Hemsley","sequence":"additional","affiliation":[{"name":"Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris O","family":"Durojaiye","sequence":"additional","affiliation":[{"name":"University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Patel","sequence":"additional","affiliation":[{"name":"University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2509-0597","authenticated-orcid":false,"given":"R.","family":"Andrew Seaton","sequence":"additional","affiliation":[{"name":"Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"2022042812395353600_dkac047-B1","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlz026","article-title":"Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK","volume":"1","author":"Chapman","year":"2019","journal-title":"JAC-Antimicrob Resist"},{"key":"2022042812395353600_dkac047-B2","doi-asserted-by":"crossref","first-page":"e049733","DOI":"10.1136\/bmjopen-2021-049733","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses","volume":"11","author":"Dimitrova","year":"2021","journal-title":"BMJ Open"},{"key":"2022042812395353600_dkac047-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciy867","article-title":"2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy","volume":"68","author":"Norris","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022042812395353600_dkac047-B4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bjid.2017.06.006","article-title":"Recommendations for outpatient parenteral antimicrobial therapy in Brazil","volume":"21","author":"Oliveira","year":"2017","journal-title":"Braz J Infect Dis"},{"key":"2022042812395353600_dkac047-B5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dku517","article-title":"Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists","volume":"70","author":"Gilchrist","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2022042812395353600_dkac047-B6","first-page":"169","article-title":"Terapia Antibiotica Iniettiva Domiciliare (TAID): il registro Italiano [Outpatient Parenteral Antibiotic Therapy (OPAT): the Italian registry]","volume":"10","author":"Esposito","year":"2002","journal-title":"Infez Med"},{"key":"2022042812395353600_dkac047-B7","first-page":"45A","article-title":"Documenting the value of OPAT: Outcome studies and patient registries","volume":"11","author":"Tice","year":"2000","journal-title":"Can J Infect Dis"},{"key":"2022042812395353600_dkac047-B8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000048563","article-title":"The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: Data from the outpatient parenteral antimicrobial therapy outcomes registries","volume":"47","author":"Tice","year":"2001","journal-title":"Chemotherapy"},{"key":"2022042812395353600_dkac047-B9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijantimicag.2004.06.004","article-title":"Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison","volume":"24","author":"Esposito","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"2022042812395353600_dkac047-B10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/49.1.149","article-title":"Ambulatory antimicrobial use: the value of an outcomes registry","volume":"49","author":"Nathwani","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"2022042812395353600_dkac047-B11","article-title":"United Kingdom Outpatient Parenteral Antimicrobial Therapy (OPAT) Initiative","author":"British Society for Antimicrobial Chemotherapy"},{"key":"2022042812395353600_dkac047-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v080.i01","article-title":"An R Package for Bayesian Multilevel Models Using Stan","volume":"80","author":"Burkner","year":"2017","journal-title":"J Statistical Software"},{"key":"2022042812395353600_dkac047-B13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.diagmicrobio.2018.07.013","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) in the UK: a cross-sectional survey of acute hospital trusts and health boards","volume":"93","author":"Durojaiye","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2022042812395353600_dkac047-B14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijantimicag.2019.04.008","article-title":"Factors associated with successful completion of outpatient parenteral antibiotic therapy (OPAT): A 10-year review from a large West London service","volume":"54","author":"Hatcher","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"2022042812395353600_dkac047-B15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2012.01.016","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years","volume":"39","author":"Barr","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"2022042812395353600_dkac047-B16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/cid\/ciz991","article-title":"Clinical and economic impact of implementing OVIVA criteria on patients with bone and joint infections in outpatient parenteral antimicrobial therapy","volume":"71","author":"Marks","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022042812395353600_dkac047-B17","first-page":"1217","article-title":"Extended stability of antimicrobial agents in administration devices","volume":"72","author":"Jenkins","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2022042812395353600_dkac047-B18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/ejhpharm-2018-001515","article-title":"Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements","volume":"27","author":"Allwood","year":"2020","journal-title":"Eur J Hosp Pharm"},{"key":"2022042812395353600_dkac047-B19","doi-asserted-by":"crossref","DOI":"10.1136\/ejhpharm-2020-002340","article-title":"Assessment of the stability of citrate-buffered piperacillin\/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements","author":"Jamieson","year":"2020","journal-title":"Eur J Hosp Pharm"},{"key":"2022042812395353600_dkac047-B20","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1136\/ejhpharm-2018-001699","article-title":"Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS Yellow Cover Document compliance for continuous infusions in an outpatient setting","volume":"27","author":"Jamieson","year":"2020","journal-title":"Eur J Hosp Pharm"},{"key":"2022042812395353600_dkac047-B21","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab141","article-title":"Assessment of ceftolozane\/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy","volume":"3","author":"Jamieson","year":"2021","journal-title":"JAC-Antimicrob Resist"},{"key":"2022042812395353600_dkac047-B22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14787210.2020.1810566","article-title":"Recent innovations and new applications of outpatient parenteral antimicrobial therapy","volume":"19","author":"Farmer","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2022042812395353600_dkac047-B23","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/jac\/dkz122","article-title":"From \u2018OPAT\u2019 to \u2018COpAT\u2019: implications of the OVIVA study for ambulatory management of bone and joint infection","volume":"74","author":"Seaton","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022042812395353600_dkac047-B24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus Intravenous Antibiotics for Bone and Joint Infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"key":"2022042812395353600_dkac047-B25","first-page":"1221","article-title":"Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity","volume":"72","author":"Fisher","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2022042812395353600_dkac047-B26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jac\/dky474","article-title":"Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy","volume":"74","author":"Underwood","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022042812395353600_dkac047-B27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2217\/fmb.15.141","article-title":"Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry","volume":"11","author":"Mir\u00f3n-Rubio","year":"2016","journal-title":"Future Microbiol"},{"key":"2022042812395353600_dkac047-B28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/jac\/dkq445","article-title":"Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service","volume":"66","author":"Mackintosh","year":"2011","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/5\/1481\/43480475\/dkac047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/5\/1481\/43480475\/dkac047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T12:40:45Z","timestamp":1651149645000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/77\/5\/1481\/6532686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,2,21]]},"published-print":{"date-parts":[[2022,4,27]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkac047","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2022,2,21]]}}}